Development of radiopharmaceuticals to target neurotensin receptors based on 68Ga and 177Lu

被引：0
|
作者：
Niculae, Dana [1 ]
Mihon, Mirela [2 ,3 ]
Leonte, Radu [2 ,3 ]
Silisteanu, Andrei [2 ,3 ]
机构：
[1] Horia Hulubei Natl Inst Phys & Nucl Engn, Radioisotopes & Radiat Metrol, Magurele, Romania
[2] Politehn Univ, Bucharest, Romania
[3] Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest, Romania
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1152
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Automated radiosynthesis of [68Ga]Ga-PSMA-11 and [177Lu]Lu-PSMA-617 on the iPHASE MultiSyn module for clinical applications
    Wichmann, Christian W.
    Ackermann, Uwe
    Poniger, Stan
    Young, Kenneth
    Nguyen, Benjamin
    Chan, Gordon
    Sachinidis, John
    Scott, Andrew M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2021, 64 (03): : 140 - 146
  • [32] Development of [68Ga]Ga/[177Lu]Lu-DOTA-NI-FAPI-04 containing nitroimidazole moiety as new FAPI radiotracers with improved tumor uptake and retention
    Luo, Yang
    Jin, WenBin
    Yan, Li
    Huang, Yanran
    Hong, Haiyan
    Wang, Ran
    Qiao, Jinping
    Kung, Hank F.
    Zhu, Lin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [33] Preclinical evaluation of novel theranostic heterodimeric ligands [68Ga]Ga/[177Lu]Lu-DOTA-FAPI-BPsfor tumor bone metastasis
    Deng, Y.
    Jin, W.
    Zhang, Z.
    Wang, X.
    Zhao, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S450 - S450
  • [34] Investigation of [177Lu]Lu-PSMA-617 therapy minimum cycle interval with [68Ga]Ga-PSMA-11 PET/CT
    Costa, G.
    Yousefzadeh-Nowshahr, E.
    Orlov, C.
    Fitzpatrick, K.
    Frey, K.
    Beer, A.
    Dewaraja, Y.
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S210 - S210
  • [35] Development of [68Ga]Ga/[177Lu]Lu-DOTA-NI-FAPI-04 Containing a Nitroimidazole Moiety as New FAPI Radiotracers with Improved Tumor Uptake and Retention
    Luo, Yang
    Jin, Wenbin
    Zang, Jie
    Wang, Guochang
    Zhu, Lin
    Kung, Hank F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 68 (01) : 348 - 360
  • [36] The Dependence of Renal 68Ga[Ga]-DOTATOC Uptake on Kidney Function and Its Relevance for Peptide Receptor Radionuclide Therapy with 177Lu[Lu]-DOTATOC
    Guehne, Falk
    Heinzig, Alexander
    Seifert, Philipp
    Drescher, Robert
    Freesmeyer, Martin
    DIAGNOSTICS, 2021, 11 (07)
  • [37] The Use of 68Ga DOTATATE PET/CT for Diagnostic Assessment and Monitoring of 177Lu DOTATATE Therapy in Pituitary Carcinoma
    Novruzov, Fuad
    Aliyev, Jamil A.
    Jaunmuktane, Zane
    Bomanji, Jamshed B.
    Kayani, Irfan
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (01) : 47 - 53
  • [38] The Rationale for the Effectiveness of Applying Radiopharmaceuticals Based on 177Lu for Radionuclide Therapy
    Dzholumbetov, Sergey K.
    Zhukovsky, Michail, V
    PHYSICS, TECHNOLOGIES AND INNOVATION (PTI-2019), 2019, 2174
  • [39] [68Ga]/[177Lu]P17-087: A potential theranostic agent targeting PSMA expressing tumor
    Kung, Hank
    Choi, Seok Rye
    Zha, Zzhihao
    Ploessl, Karl
    Alexoff, David
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S99 - S100
  • [40] [68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4
    Lau, Joseph
    Kwon, Daniel
    Rousseau, Etienne
    Zhang, Zhengxing
    Zeisler, Jutta
    Uribe, Carlos F.
    Kuo, Hsiou-Ting
    Zhang, Chengcheng
    Lin, Kuo-Shyan
    Benard, Francois
    MOLECULAR PHARMACEUTICS, 2019, 16 (11) : 4688 - 4695
12345